Mikhail Scherbakov (Michael Scherbakov)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Venues

Human vaccines & immunotherapeutics

GlaxoSmithKline Biologicals SA

This page only lists publications with an associated author ORCID identifier.

Affiliation History

GlaxoSmithKline Biologicals SA May 12o 2005

Belgium

Sr Regional medical Manager Vaccines :: Medical

Publications

Patricia Izurieta, Mikhail Scherbakov, Javier Nieto Guevara, Volker Vetter, Bruce A Mungall
Systematic review of the efficacy, effectiveness and impact of high-valency pneumococcal conjugate vaccines on otitis media. Human vaccines & immunotherapeutics 18 (1) (2022)
Alen Marijam, Ekaterina Safonova, Mikhail Scherbakov, Evgeniy Shpeer, Désirée A M van Oorschot, Alla Rudakova, Vladimir Tatochenko, Nikolay Briko
Cost effectiveness and budget impact of universal varicella vaccination in Russia. Human vaccines & immunotherapeutics 18 (5) (2022)
Leyla Namazova-Baranova, Md Ahsan Habib, Michael Povey, Kamilla Efendieva, Olga Fedorova, Marina Fedoseenko, Tatyana Ivleva, Yulia Kovshirina, Julia Levina, Artem Lyamin, Ludmila Ogorodova, Olga Reshetko, Viktor Romanenko, Inna Ryzhenkova, Irina Sidorenko, Yakov Yakovlev, Aleksandr Zhestkov, Vladimir Tatochenko, Mikhail Scherbakov, Evgeniy L Shpeer, Giacomo Casabona
A randomized trial assessing the efficacy, immunogenicity, and safety of vaccination with live attenuated varicella zoster virus-containing vaccines: ten-year follow-up in Russian children. Human vaccines & immunotherapeutics (2021)
Asmik Asatryan, Nadia Meyer, Mikhail Scherbakov, Victor Romanenko, Irina Osipova, Anna Galustyan, Olga Shamsheva, Tatiana Latysheva, Tatyana Myasnikova, Nathalie Baudson, Monique Dodet, Stebin Xavier, Lauriane Harrington, Anastasia Kuznetsova, Laura Campora, Peter Van den Steen
Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study. Human vaccines & immunotherapeutics 17 (3) (2020)
Victor Romanenko, Irina Osipova, Anna Galustyan, Mikhail Scherbakov, Nathalie Baudson, Déborah Farhi, Luis Anaya, Sherine O Kuriyakose, Nadia Meyer, Winnie Janssens
Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label study. Human vaccines & immunotherapeutics 16 (9) (2020)

Mikhail Scherbakov.css-eqlu8i{font-size:small;padding-left:4px;} (Michael Scherbakov)

Publication Activity (10 Years)

Top Topics

Top Venues

Mikhail Scherbakov (Michael Scherbakov)